Pronađeno: 1-4 / 4 radova

Autori: Rosenbaum Hanna

>> Prikaži sve rezultate

>> Sve godine

Naslov Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari Duran Gloria Giraldo Pilar Rosenbaum Hanna Giona Fiorina Petakov Milan S Terreros Munoz Eduardo Eduardo Solorio-Meza Sergio Cooper Peter A Varughese Sheeba Alon Sari Chertkoff Raul 
Info BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 78 br. , str. 14-21
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M Shankar Suma P Petakov Milan S Giraldo Pilar Rosenbaum Hanna Amato Dominick J Szer Jeffrey Chertkoff Raul Brill-Almon Einat Zimran Ari 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari Duran Gloria Mehta Atul Giraldo Pilar Rosenbaum Hanna Giona Fiorina Amato Dominick J Petakov Milan S Munoz Eduardo Terreros Solorio-Meza Sergio Eduardo Cooper Peter A Varughese Sheeba Chertkoff Raul Brill-Almon Einat 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 656-660
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M Petakov Milan S Giraldo Pilar Rosenbaum Hanna Szer Jeffrey Deegan Patrick B Amato Dominick J Mengel Eugen Tan Ee Shien Chertkoff Raul Brill-Almon Einat Zimran Ari 
Info BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX